Intellectual Property India Publishes Patent Application for 'Rnai Constructs And Methods For Inhibiting Fam13a Expression' Filed by Amgen Inc.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517013570 A) filed by Amgen Inc., Thousand Oaks, U.S.A., on Feb. 17, for 'rnai constructs and methods for inhibiting fam13a expression.'

Inventor(s) include Killion, Elizabeth Ann; Holder, Jerry Ryan; Meade, Bryan; Murray, Justin K.; Homann, Oliver R.; Griego, Briana Renee; and Veniant Ellison, Murielle Marie.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "The present application relates to compositions and methods for modulating expression of Family with Sequence Similarity 13 Member A (FAM13A) protein. In particular, the present applicatio...